Vaccine Approval News

6 Aug 20267:54 pm

Science6 Aug 2026 · 7:54 pm7:54 pm

Moderna's mRNA Flu Shot, mFlusiva, Receives FDA Approval

The U.S. FDA has approved Moderna's first mRNA flu shot, mFlusiva, for adults aged 50 to 64 with traditional approval and for those 65 and older with accelerate

6 Aug 20263:56 pm

Science6 Aug 2026 · 3:56 pm3:56 pm

Create visual

FDA Approves Moderna's mRNA Flu Vaccine Following Initial Review Refusal

The FDA has approved Moderna's mRNA seasonal flu vaccine, despite initially refusing to review it.

Vaccine Approval News

#Vaccine Approval

Moderna's mRNA Flu Shot, mFlusiva, Receives FDA Approval

FDA Approves Moderna's mRNA Flu Vaccine Following Initial Review Refusal

Discover Faster

Stay Organized

Create Effortlessly

Drive Greater Impact

Newsroom FAQs